Specialty Pharmacy

Top news of the day from across the health care landscape.

Dampened cytokine interaction may indicate asymptomatic glioma.

Every 10 cm increase in waist size found to increase risk of high-grade prostate cancer by 13%.

Approximately 325 million individuals are living with hepatitis worldwide.

Those who battled hepatitis C recount their journey to spread awareness on World Hepatitis Day.

The annual meeting of the National Association of Specialty Pharmacy will take place this September in Washington, DC.

Response rate higher among patients with HIV treated with dolutegravir compared with lopinavir/ritonavir.

Interaction between patients with cancer during chemotherapy may increase 5-year survival.

Top news of the day from across the health care landscape.

Rina Shah, PharmD, Vice President, Pharmacy Operations and Specialty Pharmacy, Walgreens, discusses how operating a specialty pharmacy associated with a retail pharmacy can be beneficial.

US Preventive Services Task Force states that screening tests for ovarian cancer are often inaccurate.

Dolutegravir-based treatment non-inferior to boosted protease inhibitor regimen in virally suppressed HIV-positive patients.

Investigators compare long-term overall and disease-free survival rates in neoadjuvant versus adjuvant radiotherapy.

Top news of the day from across the health care landscape.

Global market for HER2-positive breast cancer to increase to $9.89 billion in 2025.

A diet high in red and processed meats, sugar, and saturated fats can lead to colorectal cancer.

The FDA is requesting a new clinical study before evaluating a new drug application for baricitinib, an oral medication for moderate-to-severe rheumatoid arthritis.

The future for pharmacy is very lucrative as they press on for provider status.

Fixed-dose combination tablet containing doravirine achieved viral suppression in HIV-1 infected treatment-naïve adults.

Immunization of cows induces rapid elicitation of broadly neutralizing antibodies to HIV.

Treatment with paclitaxel or doxorubicin plus cyclophosphamide may increase the risk of metastatic breast cancer.

Novel approach may improve efficacy of pancreatic cancer treatments.

Breast microbiome may be harnessed to treat the development of breast cancer.

Tools that analyze the cancer genome provide new insight into the mechanisms that drive cancer development.

Top news of the day from across the health care landscape.

Combination treatments well tolerated amongst study participants with HIV-1 infection.

Proper dosing of Vorinostat can help expose latent HIV.

Memory T cell subtypes can be reactivated with current immunotherapy.